TPD52 is a prognostic biomarker and potential therapeutic target for ER+/PR+/HER2+ breast cancer
@article{CCO125076, author = {Xiaolin Cheng and Zhengdong Li and Xiaoqing Jia and Zhiyuan Fan and Qizhi He and Zhigang Zhuang}, title = {TPD52 is a prognostic biomarker and potential therapeutic target for ER+/PR+/HER2+ breast cancer}, journal = {Chinese Clinical Oncology}, volume = {13}, number = {3}, year = {2024}, keywords = {}, abstract = {}, issn = {2304-3873}, url = {https://cco.amegroups.org/article/view/125076} }